Publications with the same authors as the (3S)- AND (3S)- and (3R)-6, 7-Bis(Hydroxymethyl)-1H.3H-Pyrrolo[1,2-C]Thiazoles as P53 Activators. PCT/IB2019/053603, EP 19730929.7, US 17/254,048, Publication Nº WO/2019/243906 publication

Group by: Tipo Ano Order: Title Year Type of publication

Educational Publication

"Role of p53 and TAp73 in Neuroblastoma" in "Encyclopedia—the Scholarly Community Encyclopedia", Encyclopedia platafform - MDPI

Honorina Cidade (Author) (FFUP); Emilia Sousa (Author) (FFUP); Lucilia Saraiva (Author) (FFUP)

2023

Patent

(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS. PCT/IB2019/053603. Publication Number WO 2019/243906 A1

Lucilia Saraiva (Author) (FFUP)

2019

(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS. PCT/IB2019/053603. Publication Number WO 2019/243906 A1

Lucilia Saraiva (Author) (FFUP)

2018

TRYPTOPHANOL-DERIVED OXAZOLOISOINDOLINONES: SMALL-MOLECULE P53 ACTIVATORS. European patent application nº EP14739561.0 US patent application 20160347765 . Publication number WO2014207688 A1 (2014). Exportar publicação no formato APA

Lucilia Saraiva (Author) (FFUP)

2018

TRYPTOPHANOL-DERIVED OXAZOLOISOINDOLINONES: SMALL-MOLECULE P53 ACTIVATORS. European patent application nº EP14739561.0 US patent application 20160347765 . Publication number WO2014207688 A1 (2014). Exportar publicação no formato APA

Lucilia Saraiva (Author) (FFUP)

2019

TRYPTOPHANOL-DERIVED OXAZOLOISOINDOLINONES: SMALL-MOLECULE P53 ACTIVATORS. European patent application nº EP14739561.0 US patent application 20160347765 . Publication number WO2014207688 A1.

Lucilia Saraiva (Author) (FFUP)

2016

Tryptophanol-derived oxazoloisoindolinones: small-molecule p53 activators

Lucilia Saraiva (Author) (FFUP)

2022

TRYPTOPHANOL-DERIVED OXAZOLOISOINDOLINONES: SMALL-MOLECULE P53 ACTIVATORS

Lucilia Saraiva (Author) (FFUP)

2014

Scientific classification Documents

CORDIS: Health sciences

FOS: Medical and Health sciences

File name	Description	Size
https_www.google.com_patents_WO2014207688A1_cl=en&hl=pt-PT		505.97 KB

SARAIVA LUCÍLIA et al. ¿TRYPTOPHANOL-DERIVED OXAZOLOISOINDOLINONES: SMALL-MOLECULE P53 ACTIVATORS¿. Publication number WO2014207688 A1.

Lucilia Saraiva (Author) (FFUP)

2015

ROY-BZ: A SMALL MOLECULE SELECTIVE ACTIVATOR OF PROTEIN KINASE CDELTA. PCT/IB2017/050633; Publication number WO2017134637 A1.

Lucilia Saraiva (Author) (FFUP)

2017

ROY-BZ: A SMALL MOLECULE SELECTIVE ACTIVATOR OF PROTEIN KINASE CDELTA". PCT/IB2017/050633, Publication number WO2017134637 A1.

Lucilia Saraiva (Author) (FFUP)

2016

ROY-BZ: A SMALL MOLECULE SELECTIVE ACTIVATOR OF PROTEIN KINASE CDELTA. PCT/IB2017/05063. Publication number WO2017134637 A1.

Lucilia Saraiva (Author) (FFUP)

2018

New pharmaceutical compounds, methods and uses thereof”, PCT/IB2021/058241, Publication Nº WO/2022/053998

Lucilia Saraiva (Author) (FFUP)

2022

Mariana Leão, Emília Sousa, Alberto Inga, Ana Paiva, Clara Pereira, Lucília Saraiva, Madalena Pinto ¿Inibidores da interação p53-MDM2¿. WO2013/105037 A1 (2013).

Lucilia Saraiva (Author) (FFUP)

2015

Inibidores da interação p53-mdm2

Lucilia Saraiva (Author) (FFUP)

2013

Scientific classification Documents

CORDIS: Health sciences

FOS: Medical and Health sciences

File name	Description	Size
http_www.google.com_patents_LEM1_WO2013105037A1_cl=pt		598.77 KB

Another Publication in an International Scientific Journal

Xanthone as a valuable scaffold to identify new promising antitumor agents via inhibition of p53/p73:MDM2 interaction (P14). Pharmaceuticals, 2016, 9 (15), 35.

Lucilia Saraiva (Author) (FFUP)

2016

The Importance of Humanized Yeast to Better Understand the Role of Bcl-2 Family in Apoptosis: Finding of Novel Therapeutic Opportunities

Rui D Silva (Author) (Other); Stephen Manon (Author) (Other); Jorge Goncalves (Author) (FFUP); Luclia Saraiva (Author) (FFUP); Manuela Corte Real (Author) (Other)

2011

Scientific classification Indexing

ISI Web of Knowledge - 23 Citations

Scopus - 26 Citations

FOS: Basic medicine

Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease

Domingos, S (Author) (Other); Duarte, T (Author) (Other); Lucilia Saraiva (Author) (FFUP); Guedes, RC (Author) (Other); Moreira, R (Author) (Other)

2019

Indexing

ISI Web of Knowledge

Scopus - 7 Citations

Structural and Drug Targeting Insights on Mutant p53

Gomes, AS (Author) (Other); Ramos, H (Author) (Other); Inga, A (Author) (Other); Emilia Sousa (Author) (FFUP); Lucilia Saraiva (Author) (FFUP)

2021

Indexing

ISI Web of Knowledge - 4 Citations

Scopus - 20 Citations

Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment

Lopes, EA (Author) (Other); Gomes, S (Author) (Other); Lucilia Saraiva (Author) (FFUP); Santos, MMM (Author) (Other)

2019

Indexing

ISI Web of Knowledge - 4 Citations

Scopus - 6 Citations

Records 1 to 20 from 166

 

1

  2 3 4 5 6